Human Genome Research Grants (Assistance Listing 93.172)
Administered by National Institutes of Health. An Assistance Listing is the permanent catalog entry for a federal funding program — individual opportunities are issued under it and come and go.
Overview
Assistance Listing 93.172 — Human Genome Research — is a federal funding program administered by National Institutes of Health. UseGrants has tracked 77 funding opportunities issued under it, of which 56 are accepting applications right now. A further 18 are forecast — announced by the agency but not yet open. The typical award ceiling is $375,000, with the largest at $2,250,000. Historically, opportunities under this listing post most often in June and May.
Eligibility is set per opportunity, not per listing. The free UseGrants check matches your organization type and focus against every open opportunity, including these.
- Open now
- 56
- Forecast
- 18
- Opportunities tracked
- 77
- Typical ceiling
- $375K
- Largest ceiling
- $2.3M
- Assistance Listing
- 93.172
Open opportunities under 93.172
56 opportunities are accepting applications, newest first. Confirm every detail on the issuing agency’s official listing before you apply.
GREGoRi Data Coordination and Outreach Center (U01, Clinical Trials Not Allowed)
Due Oct 30, 2026National Institutes of Health · Up to $1.3M
This NIH U01 grant establishes the GREGoRi Data Coordination and Outreach Center, which coordinates the rare disease research program and makes its protocols, data, tools, and resources available to the broader community; clinical trials are not allowed. It is a research grant for universities, research institutions, and similar eligible organizations. Foreign organizations and foreign components are not eligible to apply. The award maximum is about $1.25 million. Eligibility is oriented toward research institutions rather than nonprofits, businesses, or individuals broadly.
ResearchersSchools & universitiesLarge awardGREGoRi Technology Integration Center (U01, Clinical Trials Optional)
Due Oct 30, 2026National Institutes of Health · Up to $2.3M
This NIH U01 grant establishes the GREGoRi Technology Integration Center to set standards and best practices for applying new molecular methods in rare disease diagnosis, including building a benchmarking dataset; clinical trials are optional. It is a research grant for universities, research institutions, and similar eligible organizations. Foreign organizations and foreign components are not eligible to apply. The award maximum is about $2.25 million. Eligibility is oriented toward research institutions rather than nonprofits, businesses, or individuals broadly.
ResearchersSchools & universitiesLarge awardGREGoRi Innovation Projects (U01 Clinical Trial Optional)
Due Oct 30, 2026National Institutes of Health · $3–$500K
This NIH U01 grant funds development and testing of highly innovative experimental or computational approaches for rare disease diagnosis, with clinical trials optional. It is a research grant for universities, research institutions, and similar eligible organizations, and foreign organizations and foreign components are eligible. The award maximum is about $500,000 (the listed minimum appears to be a data artifact). Eligibility is oriented toward research institutions rather than nonprofits, businesses, or individuals broadly.
ResearchersSchools & universitiesLarge awardPredoctoral to Postdoctoral Transition Award (Parent F99/K00 - Clinical Trial Not Allowed)
Due Apr 8, 2029National Institutes of Health · Amount varies
This NIH Predoctoral-to-Postdoctoral Transition Award (F99/K00) supports promising graduate students as they finish doctoral research and move into mentored postdoctoral career development, in NIH mission-relevant fields. It is a mentored training award administered through institutions; candidates may not lead an independent clinical trial but may participate in a sponsor-led one. Only domestic U.S. organizations may apply; foreign organizations are not eligible, though foreign components are allowed.
Schools & universitiesResearchersNarrow eligibilityNIH Research Educational Program - Mentoring Activities & Networks (Parent R25/UE5 - Clinical Trial Not Allowed)
Due May 5, 2029National Institutes of Health · Amount varies
This NIH Research Education Program (R25/UE5) funds mentoring activities and networks that develop the biomedical, behavioral, and clinical research workforce. It requires institutional commitment of staff, facilities, and resources, and proposed activities must be distinct from any existing federally funded training programs (such as T32) at the applicant. Only domestic U.S. organizations may apply; foreign organizations are not eligible and foreign components are not allowed. Clinical trials are not permitted.
Schools & universitiesResearchersNarrow eligibilityNIH Research Education Program - Research Experiences (Parent R25 - Clinical Trial Not Allowed)
Due May 5, 2029National Institutes of Health · Amount varies
This NIH Research Education Program (R25) funds hands-on research experiences that help build and diversify the biomedical, behavioral, and clinical research workforce. It is aimed at institutions that can provide the staff, facilities, and educational resources to run such programs, and proposed activities must be distinct from any existing federally funded training grants (such as T32). Only domestic U.S. organizations may apply; foreign organizations are not eligible and foreign components are not allowed. Clinical trials are not permitted.
Schools & universitiesResearchersNarrow eligibilityNIH Research Education Program - Courses, Curriculum & Methods (Parent R25 - Clinical Trial Not Allowed)
Due May 25, 2029National Institutes of Health · Amount varies
This NIH Research Education Program (R25) funds the development of courses, curricula, and educational methods that strengthen the biomedical, behavioral, and clinical research workforce. It is aimed at institutions that can commit staff, facilities, and educational resources, and proposed activities must be distinct from any existing federally funded training grants (such as T32) at the applicant. Only domestic U.S. organizations may apply; foreign organizations are not eligible and foreign components are not allowed. Clinical trials are not permitted.
Schools & universitiesResearchersNarrow eligibilityResearch Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Required)
Due Oct 25, 2027National Institutes of Health · Up to $375K
This NIH R15 (REAP) award funds small-scale research and student research experiences at health-professional and graduate schools that receive limited NIH funding, with a minimal-risk clinical trial required. Eligibility is restricted to degree-granting institutions that have received no more than $6 million per year of NIH support in 4 of the last 7 years; foreign organizations are not eligible. Awards reach up to about $375,000. The NIH-funding cap and institution-type limits make eligibility narrow, so verify your institution qualifies.
ResearchersSchools & universitiesNarrow eligibilityNIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)
Due Apr 5, 2027National Institutes of Health · Amount varies
This NIH STTR program (R41/R42) funds U.S. small businesses that partner with a nonprofit research institution to move scientific innovations toward commercialization. Eligibility is limited to U.S. small business concerns as defined by the SBA, and foreign organizations are not eligible. No award amount is listed.
Small businessNarrow eligibilitySBIR/STTR Commercialization Readiness Pilot (CRP) Program (Parent SB1 Clinical Trial Optional)
Due Apr 5, 2029National Institutes of Health · Amount varies
This NIH SBIR/STTR Commercialization Readiness Pilot (CRP) is restricted to U.S. small business concerns (as defined by the SBA) and helps move NIH-funded SBIR/STTR projects from late-stage development toward commercialization. It supports later-stage R&D and technical assistance such as replication studies, IND/IDE-enabling work, clinical studies, manufacturing scale-up, and regulatory support, and a significant portion may be subcontracted. Foreign organizations are not eligible to apply.
Small businessNarrow eligibilityNIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
Due Apr 5, 2027National Institutes of Health · Amount varies
This NIH/CDC/FDA SBIR program (R43/R44) funds U.S. small businesses developing scientific innovations toward commercial products through feasibility and R&D studies. Eligibility is limited to U.S. small business concerns as defined by the SBA, and foreign organizations are not eligible. No award amount is listed.
Small businessNarrow eligibilityLimited Competition: Instrumentation Grant Program for Resource-Limited Institutions (S10 - Clinical Trial Not Allowed)
Due Jan 26, 2029National Institutes of Health · $25K–$250K
This NIH S10 instrumentation grant funds resource-limited institutions to purchase state-of-the-art scientific instruments supporting biomedical research and education. It is a limited competition that invites applications only from eligible organizations, and awards range from about $25,000 to $250,000. Foreign organizations and foreign components of U.S. organizations are not eligible to apply.
Schools & universitiesResearchersNarrow eligibilityNIH Science Education Partnership Award (SEPA) (R25 - Clinical Trial Not Allowed)
Due May 25, 2029National Institutes of Health · Amount varies
The NIH Science Education Partnership Award (SEPA, R25) funds educational projects that increase understanding of biomedical research among pre-college (pre-K through grade 12) students and encourage interest in STEM careers. It suits universities, research institutions, and education-focused organizations that can run science education programs. Only domestic U.S. organizations may apply; foreign organizations are not eligible and foreign components are not allowed. Clinical trials are not permitted.
Schools & universitiesNonprofitsNarrow eligibilityAdministrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)
Due Nov 30, 2028National Institutes of Health · Amount varies
This NIH opportunity provides administrative supplements only to organizations that already hold an active, eligible NIH grant or cooperative agreement, to cover unforeseen increased costs within the scope of the existing project. New applicants without a current NIH award cannot use it. Funding is not guaranteed, and applicants must discuss requests with the awarding Institute's staff before submitting; foreign organizations may apply only consistent with the existing parent award.
ResearchersSchools & universitiesNarrow eligibilityStephen I. Katz Early Stage Investigator Research Project Grant (R01 Clinical Trial Not Allowed)
Due Aug 25, 2028National Institutes of Health · Amount varies
Open to U.S. universities, research institutions, nonprofits, and certain government/tribal organizations; foreign organizations are not eligible. This NIH R01 supports early-stage investigators pursuing a new research direction, and applications must include no preliminary data. Award size follows standard R01 limits; aimed at researchers early in their independent careers.
ResearchersSchools & universitiesNonprofitsGovernment / tribalSupport for Research Excellence (SuRE) Award (R16 Clinical Trial Not Allowed)
Due Sep 7, 2028National Institutes of Health · Up to $100K
This NIH award (SuRE, up to $100,000) funds investigator-initiated biomedical research by full-time faculty at resource-limited higher education institutions who do not currently hold other NIH research project grants, aiming to build research capacity and student research experience. Foreign organizations and their non-U.S. components are not eligible. The maximum award is under $100,000, and the application deadline is not imminent.
Schools & universitiesResearchersSmall awardNarrow eligibilitySupport for Research Excellence First Independent Research (SuRE-First) Award (R16 - Clinical Trial Not Allowed)
Due Sep 7, 2028National Institutes of Health · Up to $125K
This NIH award (SuRE-First, up to $125,000) funds investigator-initiated biomedical research by full-time faculty at resource-limited institutions who have never previously held an independent, peer-reviewed external research grant, aiming to build research capacity and provide student research experience. Foreign organizations and their non-U.S. components are not eligible. The maximum award is small, and the deadline is not imminent.
Schools & universitiesResearchersSmall awardNarrow eligibilityRuth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (Parent F32)
Due May 7, 2028National Institutes of Health · Amount varies
This NIH fellowship funds individual postdoctoral researchers who show strong potential to become independent investigators in health-related research fields, supporting mentored research training. It is an individual award (not for organizations), and foreign organizations are listed as an other-eligible applicant category. No specific funding amount is given, and the deadline is not imminent.
ResearchersIndividualsNarrow eligibilityRuth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship (Parent F31)
Due May 7, 2028National Institutes of Health · Amount varies
This NIH fellowship funds individual predoctoral students conducting dissertation research in health-related fields under a faculty sponsor, with the goal of developing them into independent researchers. It is limited to individual applicants (not organizations); foreign organizations are named as an other-eligible category, and applicants may not lead an independent clinical trial. No specific award amount is listed, and the deadline is several years out.
ResearchersIndividualsNarrow eligibilityEthical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional)
Due Nov 18, 2026National Institutes of Health · Amount varies
This NIH R01 grant funds research applications studying the ethical, legal, and social implications of human genetics and genomics, using empirical, conceptual, legal, or normative methods. Applications must include a Plan for Enhancing Diverse Perspectives (PEDP); those without one won't be reviewed. It's aimed at eligible U.S. and territorial research institutions, and the deadline is November 18, 2026.
ResearchersSchools & universitiesNarrow eligibilityEthical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional)
Due Nov 16, 2026National Institutes of Health · Up to $50K
This NIH grant (up to $50,000) funds small research projects studying the ethical, legal, and social implications (ELSI) of human genetics and genomics, including single-investigator studies, preliminary data collection, and secondary data analysis. It's aimed at eligible U.S. and territorial research institutions. The deadline is November 16, 2026.
ResearchersSmall awardNarrow eligibilityEthical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)
Due Nov 18, 2026National Institutes of Health · Amount varies
This NIH R21 grant funds exploratory and developmental research into the ethical, legal, and social implications of human genetics and genomics, particularly studies examining new or emerging genomic technologies. It's open to eligible U.S. and territorial research institutions using empirical, conceptual, legal, or normative methods. The deadline is November 18, 2026.
ResearchersSchools & universitiesNarrow eligibilityNIH Small Research Grant Program (Parent R03 Clinical Trial Not Allowed)
Due Jan 7, 2028National Institutes of Health · Up to $50K
The NIH parent Small Research Grant (R03, clinical trial not allowed) supports small, short-term projects such as pilot and feasibility studies, secondary data analysis, and methodology development. A broad range of domestic and foreign institutions may apply, including universities, tribal governments, and community-based organizations. The award is capped at about $50,000. The small budget suits research institutions pursuing limited-scope projects to generate preliminary data.
ResearchersSchools & universitiesGovernment / tribalNonprofits+2 moreNIH Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Required)
Due Jan 7, 2028National Institutes of Health · Amount varies
The NIH parent Exploratory/Developmental Research Grant (R21, clinical trial required) supports early-stage research projects with at least one clinical trial, aligned with participating NIH institutes' missions. A broad range of domestic and foreign institutions may apply, including universities, tribal governments, and community-based organizations. No specific award amount is stated. The clinical-trial requirement makes this best suited to research institutions with trial capacity.
ResearchersSchools & universitiesGovernment / tribalNonprofits+1 moreNIH Research Project Grant (Parent R01 Clinical Trial Required)
Due Jan 7, 2028National Institutes of Health · Amount varies
The NIH parent Research Project Grant (R01, clinical trial required) supports investigator-initiated research projects, with at least one clinical trial required, aligned with participating NIH institutes' missions. A broad range of domestic and foreign institutions may apply, including universities, tribal governments, and community-based organizations. No specific award amount is stated. The clinical-trial requirement makes this best suited to research institutions with trial capacity.
ResearchersSchools & universitiesGovernment / tribalNonprofits+1 moreNIH Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Not Allowed)
Due Jan 7, 2028National Institutes of Health · Amount varies
The NIH parent Exploratory/Developmental Research Grant (R21, clinical trial not allowed) supports early-stage, higher-risk research projects that may lead to breakthroughs or novel methods. A broad range of domestic and foreign institutions may apply, including universities, tribal governments, and community-based organizations. No specific award amount is stated. This is an exploratory research mechanism aimed at research institutions.
ResearchersSchools & universitiesGovernment / tribalNonprofits+1 moreNIH Research Project Grant (Parent R01 Clinical Trial Not Allowed)
Due Jan 7, 2028National Institutes of Health · Amount varies
The NIH parent Research Project Grant (R01, clinical trial not allowed) supports investigator-initiated research projects aligned with participating NIH institutes' missions, excluding clinical trials. A broad range of domestic and foreign institutions may apply, including universities, tribal governments, and community-based organizations. No specific award amount is stated. This is a core NIH research mechanism aimed at research institutions.
ResearchersSchools & universitiesGovernment / tribalNonprofits+1 moreSupporting Talented Early Career Researchers in Genomics (R01 Clinical Trial Optional)
Due Feb 26, 2027National Institutes of Health · Amount varies
An NIH/NHGRI R01 supporting early-stage investigators pursuing genomics research, across genomic sciences, medicine, data science, and ethical/legal/social implications. Foreign organizations are not eligible; domestic research institutions, minority-serving and Tribal colleges may apply, and the program targets researchers in an early-career stage. No award amount is specified. This is a research grant for academic/early-career investigators, not for general nonprofits, small businesses, or individuals.
ResearchersSchools & universitiesNew orgs OKNarrow eligibilityLimited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (UG3/UH3 Clinical Trial Optional)
Due Oct 19, 2027National Institutes of Health · Up to $650K
This NIH limited-competition award (UG3/UH3) funds collaborative innovation projects within the CTSA Program consortium to accelerate translational research. Eligibility is restricted per the funding notice, and foreign organizations and their U.S. components are not eligible, so this is aimed at institutions already in or aligned with the CTSA consortium rather than the general public. Awards run up to roughly $650,000. Review the notice's eligibility section closely, as access is limited.
ResearchersSchools & universitiesLarge awardNarrow eligibilityResearch Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed)
Due Jan 7, 2028National Institutes of Health · Up to $375K
The REAP program funds small-scale research at health professional and graduate schools that haven't been major recipients of NIH support, while giving students hands-on research experience. Eligibility is limited to institutions awarding NIH-relevant degrees that received under $6 million per year in NIH support in 4 of the last 7 years — a specific financial threshold worth checking before applying. Awards go up to $375,000.
ResearchersSchools & universitiesNarrow eligibilityAcademic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Not Allowed)
Due Jan 7, 2028National Institutes of Health · Up to $375K
An NIH Academic Research Enhancement Award (AREA/R15) for undergraduate-focused institutions that do not receive substantial NIH funding, supporting small-scale biomedical research with undergraduate involvement. Eligibility is narrow: institutions must award baccalaureate science degrees and have received no more than about $6 million per year of NIH support in 4 of the last 7 years; foreign organizations are not eligible. The award is capped at about $375,000. This is restricted to qualifying lower-NIH-funded undergraduate institutions.
ResearchersSchools & universitiesNarrow eligibilityAcademic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
Due Jan 7, 2028National Institutes of Health · Amount varies
This NIH AREA (R15) award funds small-scale research at undergraduate-focused institutions that receive limited NIH funding, emphasizing undergraduate research experiences; a minimal-risk clinical trial is required. Eligible institutions must grant baccalaureate science degrees and have received no more than about $6 million per year of NIH support in 4 of the last 7 years; foreign organizations are not eligible. No specific award amount is stated.
ResearchersSchools & universitiesNarrow eligibilityInvestigator Initiated Innovation in Computational Genomics and Data Science (R21 Clinical Trial Not Allowed)
Due Sep 7, 2027National Institutes of Health · Amount varies
This NIH (R21) opportunity supports exploratory research in computational genomics, data science, statistics, and bioinformatics relevant to basic or clinical genomic science and human health. Eligible applicants are research organizations including universities, colleges, government and tribal entities, and faith- or community-based organizations; it is intended for established research teams rather than individuals or general nonprofits. Award amounts are not specified. Methods should be generalizable and scalable to large datasets.
ResearchersSchools & universitiesGovernment / tribalNarrow eligibilityInvestigator Initiated Innovation in Computational Genomics and Data Science (R01 Clinical Trial Not Allowed)
Due Sep 7, 2027National Institutes of Health · Amount varies
This NIH (R01) opportunity funds research in computational genomics, data science, statistics, and bioinformatics relevant to basic or clinical genomic science and broadly applicable to human health. Eligible applicants are research organizations including universities, colleges, government and tribal entities, and faith- or community-based organizations; it targets established research teams rather than individuals or general nonprofits. Award amounts are not specified. Methods are expected to be generalizable and scalable to large datasets.
ResearchersSchools & universitiesGovernment / tribalNarrow eligibilitySecondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)
Due Nov 17, 2026National Institutes of Health · Up to $200K
NIH (NCI) R21 funding for secondary analysis and integration of existing datasets to study cancer risk and related outcomes; clinical trials are not allowed under this notice. Intended for research institutions and investigators, including minority-serving and tribal colleges. The listed maximum is about $200,000. This is institution-based research funding using existing data, not suited to individuals or general nonprofits.
ResearchersSchools & universitiesNarrow eligibilitySecondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)
Due Nov 6, 2026National Institutes of Health · Up to $350K
This NIH/NCI R01 grant funds secondary analysis and integration of existing datasets to study cancer risk and related outcomes such as survival and treatment response. It is a research grant for universities, research institutions, and similar eligible organizations, including various minority-serving institutions, tribal entities, and foreign organizations. The award maximum is about $350,000. Eligibility is oriented toward research institutions rather than nonprofits, small businesses, or individuals broadly, and applicants typically need access to relevant existing data.
ResearchersSchools & universitiesGovernment / tribalDeveloping novel theory and methods for understanding the genetic architecture of complex human traits (R21 Clinical Trial Not Allowed)
Due Jan 7, 2027National Institutes of Health · Amount varies
This NIH R21 funds development of novel theory and methods for understanding the genetic architecture of complex human traits, using interdisciplinary approaches, simulations, and existing large-scale datasets; no clinical trial is allowed. Eligible applicants include universities, research institutions, tribal and community organizations, and foreign organizations. It is aimed at research teams with methodological expertise. No specific award amount is stated.
ResearchersSchools & universitiesGovernment / tribalBroad eligibilityRuth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant (Parent T32)
Due May 4, 2028National Institutes of Health · Amount varies
This NIH training grant funds domestic institutions of higher education (including HBCUs, Hispanic-serving institutions, and tribal colleges) to build predoctoral and postdoctoral biomedical research training programs, not individual researchers directly. Eligibility is fairly broad among institution types, but non-domestic entities and their foreign components are excluded, and the program does not support short-term-only training plans. No dollar amount is listed, and the deadline is not near-term.
Schools & universitiesBroad eligibilityDeveloping novel theory and methods for understanding the genetic architecture of complex human traits (R01 Clinical Trial Not Allowed)
Due Nov 5, 2026National Institutes of Health · Amount varies
This NIH R01 grant supports development of novel theory and methods to understand how genetic and non-genetic factors shape complex human traits, using interdisciplinary modeling and large-scale datasets. It is a research grant aimed primarily at universities, research institutions, and similar eligible organizations, including various minority-serving institutions, tribal entities, and foreign organizations. No award amounts are specified. Clinical trials are not allowed under this opportunity, and the eligibility list is research-institution oriented rather than open to nonprofits, small businesses, or individuals broadly.
ResearchersSchools & universitiesGovernment / tribalDissemination and Implementation Research in Health (R21 Clinical Trial Optional)
Due Jan 7, 2028National Institutes of Health · Amount varies
This NIH R21 funds exploratory research on dissemination and implementation strategies for evidence-based health interventions, including studies on de-implementing low-value practices. Eligible applicants include universities and similar research institutions across NIH's mission areas. No award amount is specified.
ResearchersBroad eligibilityDissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed)
Due Jan 7, 2028National Institutes of Health · Amount varies
This NIH R03 provides smaller, shorter-term funding for research on dissemination and implementation strategies — helping evidence-based health practices get adopted and sustained, or ineffective ones phased out. Eligible applicants include universities and similar research institutions across NIH's mission areas. No award amount is specified, though R03 awards are typically modest.
ResearchersBroad eligibilityDissemination and Implementation Research in Health (R01 Clinical Trial Optional)
Due Jan 7, 2028National Institutes of Health · Amount varies
This NIH R01 funds research identifying and testing strategies to help evidence-based health interventions get adopted, scaled, and sustained — or, conversely, to phase out ineffective practices. Eligible applicants include universities, minority- and tribal-serving institutions, and similar research organizations across NIH's mission areas. No award amount is specified.
ResearchersBroad eligibilityEmerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)
Due Dec 3, 2026National Institutes of Health · Amount varies
This NIH/Fogarty K43 career development award supports an early-career scientist at an academic or research institution in a low- or middle-income country, for research that does not involve leading an independent clinical trial. Eligibility is narrow and country-restricted: only foreign institutions in qualifying LMICs may apply, U.S. organizations and their foreign components are not eligible, and some upper-middle-income G20 countries are excluded. This is not available to U.S. applicants. No specific award amount is stated.
ResearchersSchools & universitiesNarrow eligibilityEmerging Global Leader Award (K43 Independent Clinical Trial Required)
Due Dec 3, 2026National Institutes of Health · Amount varies
This NIH/Fogarty K43 career development award supports an early-career scientist at an academic or research institution in a low- or middle-income country, with a required independent clinical trial. Eligibility is narrow and country-restricted: only foreign institutions in qualifying LMICs may apply, U.S. organizations and their foreign components are not eligible, and some upper-middle-income G20 countries are excluded. This is not available to U.S. applicants. No specific award amount is stated.
ResearchersSchools & universitiesNarrow eligibilityNIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)
Due Sep 7, 2027National Institutes of Health · Amount varies
This NIH (R13) program supports conferences and scientific meetings relevant to public health and the missions of participating NIH institutes. Eligible applicants are U.S. research and education organizations including universities, government and tribal entities, and faith- or community-based organizations; foreign organizations and non-U.S. components are not eligible to apply, though some foreign components are allowed. Note that R13 conference support typically requires advance permission from the funding institute before applying. It is aimed at organizations hosting scientific conferences, not individuals. Award amounts are not specified.
ResearchersSchools & universitiesNonprofitsGovernment / tribal+1 moreNIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed)
Due Dec 4, 2026National Institutes of Health · Amount varies
This NIH R50 award provides salary support for established Research Software Engineers who build and disseminate biomedical software, tools, and algorithms. Eligible applicants include universities and research institutions; foreign (non-U.S.) organizations are not eligible to apply. It is tied to an existing research environment and specialized staff, so it suits research institutions rather than general nonprofits or individuals applying on their own. No specific award amount is stated.
ResearchersSchools & universitiesBroad eligibilitySuccessor-in-Interest (Type 6 Parent Clinical Trial Optional)
Due Jul 17, 2027National Institutes of Health · Amount varies
This NIH mechanism is narrowly limited to organizations that already hold specific NIH grants and need to transfer an award due to a change in organizational status (successor-in-interest). It is an administrative prior-approval request, not a new funding opportunity, and approval of the transfer is not guaranteed. Only current NIH grantee organizations should use it; it does not apply to individuals, new applicants, or general nonprofits. No award amount applies.
ResearchersSchools & universitiesGovernment / tribalNarrow eligibilityChange of Recipient Organization (Type 7 Parent Clinical Trial Optional)
Due Jul 12, 2027National Institutes of Health · Amount varies
This NIH mechanism is narrowly limited to organizations that already hold specific types of NIH grants and need to transfer an existing award to a new recipient institution (a change of recipient organization). It is an administrative prior-approval request, not a new funding opportunity, and there is no guarantee a transfer will be approved. Only current NIH grantee organizations should apply; it does not apply to individuals, new applicants, or general nonprofits. No award amount applies.
ResearchersSchools & universitiesGovernment / tribalNarrow eligibilityMentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Not Allowed)
Due May 7, 2027National Institutes of Health · Amount varies
This NIH mentored research scientist award (K01) provides three to five years of protected, supervised career development leading to research independence; this version does not allow leading an independent clinical trial. It is intended for individual investigators applying through eligible institutions such as universities. No award amount is listed.
ResearchersSchools & universitiesNarrow eligibilityNIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Not Allowed)
Due May 7, 2027National Institutes of Health · Amount varies
This NIH Pathway to Independence award (K99/R00) supports outstanding postdoctoral researchers transitioning to independent faculty positions; this version does not allow leading an independent clinical trial. It is intended for individual early-career investigators applying through eligible institutions such as universities; foreign organizations cannot apply. No award amount is listed.
ResearchersSchools & universitiesNarrow eligibilityMentored Clinical Scientist Research Career Development Award (Parent K08 Independent Clinical Trial Not Allowed)
Due May 8, 2027National Institutes of Health · Amount varies
This NIH mentored career development award (K08) prepares individuals with a clinical doctoral degree for research careers through supervised biomedical, behavioral, or translational research; this version does not allow leading an independent clinical trial. It is intended for individual clinician-investigators applying through eligible institutions such as universities and academic medical centers. No award amount is listed.
ResearchersSchools & universitiesNarrow eligibilityMentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Required)
Due May 7, 2027National Institutes of Health · Amount varies
This NIH mentored research scientist award (K01) provides three to five years of protected, supervised career development in biomedical, behavioral, or clinical research leading to independence, and this version requires an independent clinical trial. It is intended for individual investigators applying through eligible institutions such as universities. No award amount is listed.
ResearchersSchools & universitiesNarrow eligibilityMentored Clinical Scientist Research Career Development Award (Parent K08 Independent Clinical Trial Required)
Due May 8, 2027National Institutes of Health · Amount varies
This NIH mentored career development award (K08) prepares individuals with a clinical doctoral degree for research careers through supervised biomedical, behavioral, or translational research, and this version requires an independent clinical trial. It is intended for individual clinician-investigators applying through eligible institutions such as universities and academic medical centers. No award amount is listed.
ResearchersSchools & universitiesNarrow eligibilityNIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Required)
Due May 7, 2027National Institutes of Health · Amount varies
The NIH K99/R00 Pathway to Independence Award supports postdoctoral researchers transitioning to independent faculty positions, covering a mentored phase followed by several years of independent research funding. Applications are submitted through eligible research institutions — universities, minority-serving colleges, and similar organizations — on behalf of the individual awardee. No award amount is specified, and a clinical trial component is required for this version.
ResearchersBroad eligibilityMentored Quantitative Research Development Award (Parent K25 Independent Clinical Trial Not Allowed)
Due May 7, 2027National Institutes of Health · Amount varies
The NIH K25 award supports quantitative scientists and engineers (e.g., in math, statistics, computer science, or physics) who want to redirect their research toward NIH-relevant health questions, providing protected time for mentored study. It's submitted through eligible research institutions on behalf of an individual investigator, and excludes those leading an independent clinical trial. No award amount is specified.
ResearchersBroad eligibilityCompeting Revisions to Existing NIH Single Project Research Grants and Cooperative Agreements (Clinical Trial Optional)
Due Nov 24, 2026National Institutes of Health · Amount varies
NIH mechanism allowing existing award recipients to apply for revision (supplemental) funding to expand a current NIH grant or cooperative agreement, only in response to a specific Notice of Special Interest. Restricted to organizations that already hold an active NIH single-project award. No award amount is specified. Because applicants must already be NIH grantees and respond to a matching NOSI, eligibility is narrow and not open to new applicants.
ResearchersSchools & universitiesNarrow eligibility
Forecast opportunities under 93.172
18 opportunities have been announced by the issuing agency but are not accepting applications yet. Forecast notices usually carry no deadline and no application package until they post.
Previously issued under this listing
Past rounds are the best guide to what the next one will look like — the scope, the award size, and the time of year it lands.
When 93.172 opportunities post
Across the 77 opportunities UseGrants has tracked under this listing, postings cluster in June, May, November, December. Federal program cycles repeat, so a listing that missed you this year is worth watching for the next round.
- June19 opportunities
- May11 opportunities
- November10 opportunities
- December9 opportunities
What is Assistance Listing 93.172?
93.172 is the federal Assistance Listing (formerly CFDA) number for Human Genome Research, administered by National Institutes of Health. An Assistance Listing is the permanent catalogue entry for a funding program; individual notices of funding opportunity are issued under it, each with its own deadline and eligibility. UseGrants has tracked 77 such notices.
Are there open 93.172 grants right now?
Yes — 56 opportunities are currently accepting applications under 93.172, listed on this page with their deadlines and award amounts. 18 more are forecast: announced, but not yet open to applicants. Verify each on the issuing agency's official listing before you apply.
How much funding do 93.172 grants award?
The typical award ceiling for an opportunity under 93.172 is $375,000, ranging up to $2,250,000. Award floors and ceilings are set per opportunity — check the specific notice you intend to apply to.
Which agencies issue grants under 93.172?
National Institutes of Health has issued the opportunities UseGrants tracks under this listing. UseGrants is an independent aggregator compiling public Grants.gov records — always confirm current details on the agency's own listing.
Who applies to 93.172, and what it sits alongside
Related federal programs
Source: public Grants.gov opportunity records. Assistance Listing numbers and program titles are as published by the issuing agency. UseGrants is an independent aggregator, not a federal agency — always confirm the current deadline, eligibility and award amount on the official listing before you apply.